Our websites may use cookies to personalize and enhance your experience. By continuing without changing your cookie settings, you agree to this collection. For more information, please see our University Websites Privacy Notice.

Kelley Newlin Lew

DNSc, RN, CDE, FAAN

Associate Professor

She/Her/Hers

Research/Scholarship Interests

Type 1 diabetes
Type 2 diabetes
Community-based participatory research
Health equity

Eduation

DNSc, Yale University, School of Nursing
MSN, Yale University, School of Nursing
BSN, Florida Atlantic University (FAU), College of Nursing
BA (History), Arizona State University, College of Arts and Sciences

Honors & Awards

2016 Fellow, American Academy of Nursing
2013 Semi-Finalist, Robert Wood Johnson Nurse Faculty Scholars Fellowship
2010 Rising Star Nurse Scientist Award, Eastern Nursing Research Society
2010-2011 NIH/NYU CTSA KL2 Fellowship
2007 Consultation, Peer Programs in Diabetes, World Health Organization
2006-2009 NIH F32 Postdoctoral Fellowship
2006-2008 NIH Extramural Loan Repayment Program for Health Disparities Research
2006 Distinguished Alumna Award, FAU College of Nursing
2002-2006 NIH F31 Predoctoral Fellowship
2000 Yale Alumni Scholarship Award, Yale University School of Nursing
1997 FAU University Scholar Award
1997 FAU College of Nursing Clinical Excellence Award

Selected Publications

A full list of Dr. Newlin Lew’s selected publications can be found here:

A portrait of associate professor Kelley Newlin Lew

Email	kelley.newlin_lew@uconn.edu
Office Location	SH 214
Campus	Storrs

Feb 27 InCHIP Lecture Series: Cardiovascular Disease and Depression 12:30pm

InCHIP Lecture Series: Cardiovascular Disease and Depression

Thursday, February 27th, 2025

12:30 PM - 01:30 PM

Virtual

In Recognition of Heart Health Month
Kenneth E. Freedland, Ph.D., Washington University School of Medicine in St. Louis
Topic: Cardiovascular Disease and Depression
February 27, 2025 | 12:30 PM | WebEx
RSVP
Dr. Freedland is a Professor of Psychiatry and Psychology at Washington University School of Medicine in St. Louis. Most of his research has focused on depression in patients with heart failure or coronary heart disease. He has also conducted studies of other psychiatric comorbidities, behavioral problems such as poor self-care, and social determinants of health in patients with heart failure. He has been the principal investigator or a co-investigator on both single-site and multicenter trials of interventions for depression in cardiac patients and has served on clinical trial review committees for the National Heart, Lung, and Blood Institute (NHLBI) and the Patient-Centered Outcomes Research Institute (PCORI). He also has expertise in behavioral trial methodology. Dr. Freedland is the founder of the Society of Behavioral Medicine’s Cardiovascular Disease Special Interest Group and of the Behavioral Medicine Research Council, and a fellow of multiple organizations including the Academy of Behavioral Medicine Research. He was the Program Director of the annual NIH Summer Institute on Randomized Behavioral Clinical Trials from 2020 to 2024. He has been a member of the Summer Institute faculty since 2007 and the faculty of the NIH-funded ORBIT Institute on Developing Behavioral Treatments to Improve Health since 2022. He has also served as an Associate Editor of Psychosomatic Medicine and Editor-in-Chief of Health Psychology.

Contact Information:
lectureseries@chip.uconn.edu

More